The present invention relates to humanized antibodies and binding proteins thereof, capable of binding to T cells exhibiting {HEAD ~ particular variable beta chains}, and particularly those subpopulations expressing {TAIL ~ human V} beta 5.2 and 5.3, and V beta 8.1 
The present invention relates to humanized antibodies and binding proteins thereof , capable of binding to T cells exhibiting { HEAD ~ particular variable beta chains } , and particularly those subpopulations expressing { TAIL ~ human V } beta 5.2 and 5.3 , and V beta 8.1
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH